Skip to main content
Veterinary Medicines

Ketamidor 100 mg/ml - Injektionslösung für Tiere

Authorised
  • Ketamine hydrochloride

Product identification

Medicine name:
Ketamidor 100 mg/ml - Injektionslösung für Tiere
Ketador Vet. 100 mg/ml injektionsvæske, opløsning
Active substance:
  • Ketamine hydrochloride
Target species:
  • Dog
  • Cat
  • Pig
  • Cattle
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Ketamine hydrochloride
    115.33
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
    • Pig
      • Meat and offal
        0
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Dog
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Cat
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX03
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • Clear glass vial, type I (Ph. Eur.) with bromobutyl-rubber stopper type I (Ph.Eur.) and aluminium cap, packed in a cardboard box. Package size: 1 x 10 ml
  • Clear glass vial, type I (Ph. Eur.) with bromobutyl-rubber stopper type I (Ph.Eur.) and aluminium cap, packed in a cardboard box. Package size: 1 x 50 ml
  • Clear glass vial, type I (Ph. Eur.) with bromobutyl-rubber stopper type I (Ph.Eur.) and aluminium cap, packed in a cardboard box. Package size: 5 x 10 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetviva Richter GmbH
Responsible authority:
  • Danish Health And Medicines Authority
Authorisation number:
  • 49994
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0009/001
Concerned member states:
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Netherlands
  • Poland
  • Portugal
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, INJEKTIONSVÆSKE, OPLØSNING 100 MG-ML)
Published on: 29/06/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."